News Releases

Month Year

Email Alerts

Dec 7, 2006

Insmed to Host Litigation Update Conference Call
Dec 6, 2006

Insmed Patent Litigation Verdict Announced
Nov 21, 2006

Insmed to Present at Upcoming Investor Conference in NYC
Nov 3, 2006

Insmed Incorporated Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2006
Oct 31, 2006

Insmed Inc. to Announce 2006 Third Quarter Financial Results
Oct 31, 2006

Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Oct 30, 2006

Insmed to Present at Upcoming Conferences
Oct 25, 2006

Former Amgen Manufacturing Executive Joins Insmed
Oct 24, 2006

Insmed Announces Addition of Top 25 Patent Lawyer to Litigation Team
Oct 17, 2006

Insmed to Present at the BIO Investor Forum Meeting
Oct 16, 2006

Insmed Sues Tercica for False Advertising
Oct 5, 2006

Insmed Provides Update Concerning Virginia Unfair Competition Litigation
Sep 6, 2006

Insmed to Present at the BioCentury NewsMakers in the Biotech Industry Conference
Aug 8, 2006

Insmed Incorporated Reports Financial Results for the First Half and Second Quarter Ended June 30, 2006
Aug 7, 2006

Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
Jul 31, 2006

Phyton Biotech Signs Development Agreement With Insmed
Jul 19, 2006

Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
Jul 11, 2006

Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Jul 5, 2006

European Medicines Agency Validates Insmed's Regulatory Application For Marketing IPLEX(TM) in Europe
Jul 5, 2006

Court Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at Trial
Jun 27, 2006

Insmed Presents Positive IPLEX(TM) Data At ENDO 2006
Jun 22, 2006

Insmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; Company Also to Present Data on the Unique Pharmacokinetics of IPLEX
Jun 13, 2006

Court Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against Insmed
Jun 9, 2006

Insmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and Pricing
May 25, 2006

INSMED Announces IPLEX(TM) Availability Nationwide for Children with Severe Short Stature; IPLEX Launch Marked By The First Product Shipments To Patients in States Across the Country
May 12, 2006

Insmed Incorporated to Present at the Rodman & Renshaw 3rd Annual Healthcare Conference
May 8, 2006

Insmed Incorporated Reports Financial Results for the First Quarter Ended March 31, 2006
May 2, 2006

Insmed Inc. to Webcast 2006 First Quarter Financial Results Conference Call, Monday May 8, 2006 at 4:30 p.m. (ET)
May 1, 2006

IPLEX(TM) Demonstrates Significant, Dose-Dependent Increases in Growth Rate
Apr 26, 2006

Insmed Announces Podium Presentation at the Pediatric Academic Societies' 2006 Annual Meeting
Apr 25, 2006

NORD Honors Insmed for Role in Developing Treatments for Rare Diseases
Mar 22, 2006

Insmed Announces Additional Information in Compliance with NASDAQ Rules
Mar 15, 2006

Insmed Completes $46 Million Public Offering; Underwriters Exercise In Full Option to Purchase Additional Shares
Mar 10, 2006

Insmed Prices $40 Million Equity Offering
Mar 6, 2006

Insmed Incorporated Announces Proposed Public Offering of Common Stock
Mar 2, 2006

Insmed Incorporated Reports Financial Results for the Fourth Quarter and Twelve-Months of 2005
Feb 23, 2006

Insmed to Announce 2005 Fourth Quarter and Year End Financial Results; Thursday, March 2
Feb 3, 2006

Insmed Incorporated Files Shelf Registration Statement
Jan 4, 2006

U. of Rochester Initiates Phase 2 Clinical Trial of Insmed's iPlex for the Treatment of Myotonic Muscular Dystrophy; Trial Funded by NIH and MDA Grants
Dec 12, 2005

FDA Approves Insmed's Orphan Drug, IPLEX, for the Treatment of Severe Primary IGF-1 Deficiency; The First Once-Daily Therapy for the Treatment of Severe Primary IFG-1 Deficiency
Dec 8, 2005

Insmed Responds to Complaint Filed by Tercica
Nov 28, 2005

Insmed to Present at the Lazard Capital Markets Life Sciences Conference
Nov 5, 2005

Insmed Incorporated Reports Financial Results for the Third Quarter and First Nine Months of 2005
Nov 2, 2005

Insmed to Present at the Rodman and Renshaw 7th Annual Healthcare Conference
Nov 1, 2005

Insmed to Release Third Quarter Financial Results; Thursday, November 3
Oct 25, 2005

Insmed Receives European Orphan Drug Designation for SomatoKine for the Treatment of Extreme Insulin Resistance; Company to Initiate Clinial Trial in Type A Insulin Resistance
Oct 25, 2005

FDA to Review Insmed's Complete Response to Approvable Letter for iPlex
Oct 24, 2005

Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
Oct 18, 2005

Insmed to Present at the BIO Investor Forum Conference
Oct 17, 2005

Insmed Submits Response to FDA Approvable Letter for iPlex

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation

Download

Our Global Company

Current Clinical Trials

Our Research Team

Our Global Company

Current Clinical Trials

Our Research Team

Footer